Skip to main content
Botany 3% exam weight

Topic 10

Part of the INI CET (AIIMS PG) study roadmap. Botany topic pharma-010 of Botany.

Antimicrobial Agents: Quinolones, Aminoglycosides, and Tetracyclines covers quinolones, aminoglycosides, and tetracyclines for INI CET (AIIMS PG).

Fluoroquinolones:

  • Mechanism: Inhibit bacterial DNA gyrase (topoisomerase II) and topoisomerase IV — essential for DNA supercoiling and replication
  • Bactericidal
  • Examples: Ciprofloxacin (highest Pseudomonas activity), Levofloxacin (L-isomer), Moxifloxacin (broadest — anaerobic coverage), Ofloxacin, Norfloxacin (UTI only — poor systemic absorption)

Spectrum:

  • Gram-negatives: E. coli, Klebsiella, Salmonella, Shigella, Neisseria, Pseudomonas
  • Gram-positives: Some coverage (S. pneumoniae — levofloxacin, moxifloxacin; atypicals — Mycoplasma, Chlamydia, Legionella)
  • Atypical mycobacteria (ciprofloxacin)

Adverse Effects (all fluoroquinolones — BLACK BOX WARNINGS):

  1. Tendon rupture (Achilles tendon — especially >60 years, corticosteroids): Fluoroquinolone-associated tendinopathy
  2. QT prolongation (moxifloxacin > levofloxacin > ciprofloxacin)
  3. CNS effects: Convulsions, confusion (especially in elderly)
  4. Photosensitivity
  5. Cartilage damage: Avoid in children <18 years (arthropathy in immature animals)
  6. C. difficile colitis (broad spectrum)
  7. Glycemic disturbances ( hypoglycemia in diabetics)

Aminoglycosides:

  • Mechanism: Bind to 30S ribosomal subunit → misreading of mRNA → bactericidal
  • Examples: Gentamicin, Tobramycin (Pseudomonas), Amikacin (most resistant), Streptomycin (TB), Neomycin (topical)
  • Spectrum: Primarily gram-negative aerobes (E. coli, Klebsiella, Pseudomonas, Acinetobacter); also used synergistically with β-lactams for gram-positive infections (enterococcal endocarditis)
  • PK/PD: Concentrations-dependent killing (high peak/MIC ratio); post-antibiotic effect
  • Monitoring: Trough levels (toxicity); Peak levels (efficacy) — especially in patients with altered renal function

Adverse Effects (Aminoglycosides):

  • Nephrotoxicity (most common — accumulates in renal cortex; tubular necrosis)
  • Ototoxicity (vestibular and cochlear — cochlear: high-frequency hearing loss first; vestibular: vertigo, ataxia)
  • Neuromuscular blockade (rare — avoid with myasthenia gravis; synergism with muscle relaxants)

Exam Tip for INI CET (AIIMS PG): In endocarditis due to enterococci, the combination of Penicillin G + Gentamicin is synergistic — gentamicin provides rapid bacterial killing while penicillin provides sustained inhibition. Gentamicin alone is NOT effective against enterococci.

Tetracyclines:

  • Mechanism: Bind to 30S subunit (blocking A site) → prevent tRNA attachment → bacteriostatic
  • Examples: Tetracycline, Doxycycline, Minocycline, Demeclocycline
  • Spectrum: Broad — Rickettsia ( Rocky Mountain spotted fever), Chlamydia, Mycoplasma, Borrelia (Lyme disease), atypical pneumonia, cholera, acne (Propionibacterium)
  • Doxycycline: Most commonly used tetracycline; good oral absorption; less fatty accumulation than tetracycline; used for STD prophylaxis (ceftriaxone + doxycycline for gonorrhea + chlamydia)

Adverse Effects (Tetracyclines):

  • GI upset (esophagitis — take with plenty of water; avoid lying down)
  • Photosensitivity (especially doxycycline)
  • Tooth discoloration and enamel hypoplasia (deposits in developing teeth and bones) — AVOID in children <8 years and pregnancy
  • Pseudotumor cerebri (benign intracranial hypertension)
  • Fanconi-like syndrome (expired tetracyclines — renal tubular acidosis)
  • Hepatotoxicity (especially in pregnancy)

Other Related Drugs:

  • Glycylcyclines: Tigecycline — broader tetracycline (,克服 tetracycline resistance); used for complicated skin/soft tissue and intra-abdominal infections when other options unavailable; GI side effects prominent
  • Oxazolidinones: Linezolid — binds to 23S rRNA of 50S (not the A site); bacteriostatic for most gram-positives; active against MRSA, VRE, penicillin-resistant pneumococci; SAE: Thrombocytopenia with prolonged use; MAO inhibition (serotonin syndrome with SSRIs — CONTRAINDICATED)